Difference between revisions of "Yao X, et al. PLoS ONE (2013) cited as Ref 435 in DOI: 10.1038/s41392-020-0110-5 (Q9698)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2013, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): e57188--, #quickstatements; #temporary_batch_1590074839150) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | PLoS ONE | ||
| Property / Published In Name String: PLoS ONE / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 8 | ||
| Property / Volume: 8 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation neovascularization and tumor initiation by glioma stem-like cells (English) | ||
| Property / title: Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation neovascularization and tumor initiation by glioma stem-like cells (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | e57188-- | ||
| Property / Page(s): e57188-- / rank | |||
| + | Normal rank | ||
Latest revision as of 15:41, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Yao X, et al. PLoS ONE (2013) cited as Ref 435 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Yao X
0 references
2013
0 references
PLoS ONE
0 references
8
0 references
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation neovascularization and tumor initiation by glioma stem-like cells (English)
0 references
e57188--
0 references
